203 related articles for article (PubMed ID: 24892548)
1. Directed evolution of human heavy chain variable domain (VH) using in vivo protein fitness filter.
Kim DS; Song HN; Nam HJ; Kim SG; Park YS; Park JC; Woo EJ; Lim HK
PLoS One; 2014; 9(6):e98178. PubMed ID: 24892548
[TBL] [Abstract][Full Text] [Related]
2. Increased Fab thermoresistance via VH-targeted directed evolution.
Entzminger KC; Johnson JL; Hyun J; Lieberman RL; Maynard JA
Protein Eng Des Sel; 2015 Oct; 28(10):365-77. PubMed ID: 26283664
[TBL] [Abstract][Full Text] [Related]
3. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
4. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
[TBL] [Abstract][Full Text] [Related]
5. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
Rouet R; Dudgeon K; Christie M; Langley D; Christ D
J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
[TBL] [Abstract][Full Text] [Related]
6. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
Davies J; Riechmann L
Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
[TBL] [Abstract][Full Text] [Related]
7. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
[TBL] [Abstract][Full Text] [Related]
8. Biophysical properties of human antibody variable domains.
Ewert S; Huber T; Honegger A; Plückthun A
J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
[TBL] [Abstract][Full Text] [Related]
9. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
10. Sequence determinants of protein aggregation in human VH domains.
Dudgeon K; Famm K; Christ D
Protein Eng Des Sel; 2009 Mar; 22(3):217-20. PubMed ID: 18957405
[TBL] [Abstract][Full Text] [Related]
11. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
[TBL] [Abstract][Full Text] [Related]
12. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.
Muyldermans S; Atarhouch T; Saldanha J; Barbosa JA; Hamers R
Protein Eng; 1994 Sep; 7(9):1129-35. PubMed ID: 7831284
[TBL] [Abstract][Full Text] [Related]
13. A large human domain antibody library combining heavy and light chain CDR3 diversity.
Chen W; Zhu Z; Feng Y; Dimitrov DS
Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941
[TBL] [Abstract][Full Text] [Related]
14. Germline-Dependent Antibody Paratope States and Pairing Specific V
Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
Front Immunol; 2021; 12():675655. PubMed ID: 34447370
[TBL] [Abstract][Full Text] [Related]
15. Conserved aromatic residues as determinants in the folding and assembly of immunoglobulin variable domains.
Campion SR
Mol Immunol; 2016 Feb; 70():63-71. PubMed ID: 26742085
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.
Tobin G; Thunberg U; Johnson A; Eriksson I; Söderberg O; Karlsson K; Merup M; Juliusson G; Vilpo J; Enblad G; Sundström C; Roos G; Rosenquist R
Blood; 2003 Jun; 101(12):4952-7. PubMed ID: 12586612
[TBL] [Abstract][Full Text] [Related]
17. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
Bond CJ; Marsters JC; Sidhu SS
J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
[TBL] [Abstract][Full Text] [Related]
18. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.
Tiller T; Schuster I; Deppe D; Siegers K; Strohner R; Herrmann T; Berenguer M; Poujol D; Stehle J; Stark Y; Heßling M; Daubert D; Felderer K; Kaden S; Kölln J; Enzelberger M; Urlinger S
MAbs; 2013; 5(3):445-70. PubMed ID: 23571156
[TBL] [Abstract][Full Text] [Related]
19. Selection of non-aggregating VH binders from synthetic VH phage-display libraries.
Arbabi-Ghahroudi M; MacKenzie R; Tanha J
Methods Mol Biol; 2009; 525():187-216, xiii. PubMed ID: 19252860
[TBL] [Abstract][Full Text] [Related]
20. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
